ID   CLF-PED-015-T
AC   CVCL_RS38
SY   CLF_PEDS015T; Peds015T; PEDS015T; CPDM_0167X
DR   Wikidata; Q54813632
RX   PubMed=27329820;
CC   Part of: Center for Patient Derived Models (CPDM) at Dana-Farber Cancer Institute cell line panel.
CC   Population: Caucasian.
CC   Omics: Deep exome analysis.
CC   Omics: Genome sequenced (low read coverage).
CC   Omics: Transcriptome analysis by RNAseq.
CC   Derived from site: Metastatic; Brain, left occipital lobe; UBERON=UBERON_0002806.
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   11Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 8
//
RX   PubMed=27329820; DOI=10.1038/ncomms11987; PMCID=PMC4917959;
RA   Hong A.L., Tseng Y.-Y., Cowley G.S., Jonas O., Cheah J.H., Kynnap B.D.,
RA   Doshi M.B., Oh C., Meyer S.C., Church A.J., Gill S., Bielski C.M.,
RA   Keskula P., Imamovic A., Howell S., Kryukov G.V., Clemons P.A.,
RA   Tsherniak A., Vazquez F., Crompton B.D., Shamji A.F.,
RA   Rodriguez-Galindo C., Janeway K.A., Roberts C.W.M., Stegmaier K.,
RA   van Hummelen P., Cima M.J., Langer R.S., Garraway L.A.,
RA   Schreiber S.L., Root D.E., Hahn W.C., Boehm J.S.;
RT   "Integrated genetic and pharmacologic interrogation of rare cancers.";
RL   Nat. Commun. 7:11987.1-11987.9(2016).
//